News
Sotyktu significantly outperformed placebo for the treatment of psoriatic arthritis in a phase 3 trial, meeting key endpoints at 16 weeks, according to late-breaking data presented at the American ...
Zachary High senior Kaymin Hardnett was recently named second place winner in the Crime Stoppers Drug Public Service ...
2d
Clinical Trials Arena on MSNJ&J’s psoriatic arthritis therapy trial meets endpointsUS-based pharmaceutical company Johnson & Johnson (J&J) has reported positive results from a Phase IIIb trial of its ...
Introducing Hot Shots, a series that examines how Ozempic and other GLP-1 drugs have transformed the way we think about our bodies, weight loss, and wellness. The first time Heather’s doctor suggested ...
Based on clinical trial data, abatacept was not associated with increased malignancy risks in RA or PsA; observational data indicated a higher risk vs other b/tsDMARDs.
Several types of medication can effectively treat PsA symptoms. Certain over-the-counter (OTC) medications, such as ibuprofen, may help reduce symptoms. If OTC drugs don’t reduce your joint pain ...
Secukinumab treatment reduces bone erosion volume and enhances partial healing of erosions in patients with psoriatic ...
Continuing PSA screening in older men is common practice but not recommended, highlighting the need for clearer guidance.
I think combination therapy is coming; it’s just a question of which combinations,’ says Arthur Kavanaugh, MD.
Long-term extension analysis of the phase 3b APEX study (NCT04882098) through 3 years of treatment will further assess the sustained efficacy of guselkumab (Tremfya; Johnson & Johnson) in limiting ...
The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection), a radioactive diagnostic agent for prostate cancer detection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results